Trends in Antibiotic Resistance of Nosocomial and Community-Acquired Infections in Italy

Author:

Cerini Paola1,Meduri Francesca Rita12,Tomassetti Flaminia13ORCID,Polidori Isabella1,Brugneti Marta14,Nicolai Eleonora3ORCID,Bernardini Sergio35,Pieri Massimo35ORCID,Broccolo Francesco16

Affiliation:

1. Cerba Healthcare Italia srl, Viale Roma 190/A, Guidonia Montecelio, 00012 Rome, Italy

2. Microbiology and Virology Laboratory, Department of Molecular Medicine, University of Rome “La Sapienza”, 00185 Rome, Italy

3. Biochemistry Laboratory, Department of Experimental Medicine, University of Rome “Tor Vergata”, 00133 Rome, Italy

4. Microbiology and Virology Laboratory, Department of Experimental Medicine, University of Rome “Tor Vergata”, 00133 Rome, Italy

5. Department of Laboratory Medicine, “Tor Vergata” University Hospital, Viale Oxford 81, 00133 Rome, Italy

6. Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, 73100 Lecce, Italy

Abstract

The World Health Organization has recently identified three categories of pathogens, namely: critical, high, and medium priority, according to the need for new antibiotics. Critical priority pathogens include carbapenem-resistant microorganism (CPO) such as A. baumannii and P. aeruginosa, K. pneumoniae, and Enterobacter spp., whereas vancomycin-resistant E. faecium (VRE), methicillin and vancomycin-resistant S. aureus (MRSA) are in the high priority list. We compared the trend of antimicrobial resistants (AMRs) in clinical isolates, divided by year and bacteria spp., of samples obtained from nosocomial and community patients. Patient records were collected, including age, sex, site of infection, isolated organisms, and drug susceptibility patterns. From 2019 to 2022, a total of 113,635 bacterial isolates were tested, of which 11,901 resulted in antimicrobial resistants. An increase in the prevalence of several antibiotics resistant bacteria was observed. Specifically, the percentage of CPO cases increased from 2.62% to 4.56%, the percentage of MRSA increased from 1.84% to 2.81%, and the percentage of VRE increased from 0.58% to 2.21%. AMRs trend resulted in increases in CPO and MRSA for both community and nosocomial. Our work aims to highlight the necessity of preventive and control measures to be adopted in order to reduce the spread of multidrug-resistant pathogens.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference41 articles.

1. World Health Organization (WHO) (2017). Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis.

2. Antimicrobial Resistance: A Global Emerging Threat to Public Health Systems;Ferri;Crit. Rev. Food Sci. Nutr.,2017

3. Antimicrobial Resistance: A Global Multifaceted Phenomenon;Prestinaci;Pathog. Glob. Health,2015

4. Intrinsic and Acquired Resistance Mechanisms in Enterococcus;Hollenbeck;Virulence,2012

5. Antibacterial Resistance Worldwide: Causes, Challenges and Responses;Levy;Nat. Med.,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3